PLIVA, Inc. Buys Novartis Corporation Generics Unit In Spain For $25.6 Million
ZAGREB, Feb 15 (Reuters) - Croatian drugmaker Pliva (PLVxq.L: Quote, Profile, Research) said it had acquired Uso Racional, a Spanish subsidiary of Novartis's (NOVN.VX: Quote, Profile, Research) generics division Sandoz, for 21.5 million euros ($25.6 million).